Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial.

Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. Am Heart J. 2014 Dec; 168(6):869-77.e1.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Drug Monitoring
Drug Therapy, Combination
Electrocardiography
Female
Hemorrhage
Humans
Lactones
Male
Middle Aged
Myocardial Infarction
Platelet Aggregation Inhibitors
Pyridines
Secondary Prevention
Stroke
Survival Analysis
Ticlopidine
Treatment Outcome

authors with profiles

Robert Harrington